Skip to content
S9570Senate2023-2024 SessionSame asA10327

Guarantee Fair Pharmacy Payments

Official title

“Relates to payments by a pharmacy benefit manager to in-network pharmacies”

Sponsor Neil D. BreslinSD-46Affects Health
Status
In Senate Committee
Health
Impact
7/10
Significant
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill requires pharmacy benefit managers to reimburse in-network pharmacies at or above the national drug acquisition cost plus a minimum professional dispensing fee.

Why it matters

  1. Helps protect local and independent pharmacies. by ensuring they are reimbursed at or above their actual drug acquisition costs, which could prevent closures due to unprofitable reimbursement rates from pharmacy benefit managers (PBMs).

  2. Improves patient access and continuity of care. by reducing the financial pressure on in-network pharmacies, making it less likely that patients will face pharmacy deserts or disruptions in medication availability.

  3. Increases transparency and fairness in PBM reimbursement practices. , requiring PBMs to use standardized, federally-recognized drug cost benchmarks (NADAC or actual acquisition cost) and a clear, minimum dispensing fee, rather than arbitrary or opaque reimbursement formulas.

  4. Addresses special costs for specialty or high-cost medications,. such as those requiring unique packaging or shipping, by mandating additional reimbursement when standard dispensing fees are inadequate, ensuring pharmacies are not forced to dispense at a loss.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Guarantee Fair Pharmacy Payments

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Neil D. Breslin

Senator · Senate District 46

Chair, Ethics And Internal GovernanceChair, Insurance

No co-sponsors yet.

History

  1. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A10327Assembly

Set Pharmacy Payment Minimums

In Assembly Committee · Health · Sponsor John T. McDonald III

Impact 7 · Significant0% to pass

Full text

2 pagesUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

9570

IN SENATE

May 16, 2024

Introduced by Sen. BRESLIN -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the public health law, in relation to payments by pharmacy benefit managers to in-network pharmacies

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 1 of section 280-a of the public health law is amended by adding two new paragraphs (j) and (k) read as follows:

(j) "Pharmacy acquisition cost rate" means the cost paid by an in-network pharmacy to acquire generic, brand name drugs or biologic products pursuant to cost invoices from a manufacturer or a wholesaler.

(k) "National average drug acquisition cost" means the monthly survey of retail pharmacies conducted by the federal Centers for Medicare and Medicaid Services (CMS) to determine average acquisition cost for Medicaid covered outpatient drugs.

§ 2. Subdivision 3 of section 280-a of the public health law, as amended by chapter 128 of the laws of 2022, is amended to read as follows:

3. Prescriptions. (a) A pharmacy benefit manager may not substitute or cause the substituting of one prescription drug for another in dispensing a prescription, or alter or cause the altering of the terms of a prescription, except with the approval of the prescriber or as explicitly required or permitted by law, including regulations of the department of financial services or the department of health. The superintendent and commissioner, in coordination with each other, are authorized to promulgate regulations to determine when substitution of prescription drugs may be required or permitted.

(b) To the extent permitted under federal law, a pharmacy benefit manager shall pay an in-network pharmacy at minimum at the national average drug acquisition cost (NADAC) rate or at the pharmacy acquisition cost rate if greater or there is not a NADAC rate, plus a professional dispensing fee that is at minimum the professional dispensing fee paid under the state medical assistance program. For brand name medications and biologic products that require special packaging, ship-

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD15487-03-4

ping or other costs to be incurred by the pharmacy for the dispensing process that is greater than the professional dispensing fee paid by the state medical assistance program, in-network pharmacies shall be paid a professional dispensing fee for these costs to ensure an in-network pharmacy is not paid less than its cost to acquire and dispense medications.

§ 3. The opening paragraph of subdivision 4 of section 280-a of the public health law, as added by chapter 828 of the laws of 2021, is amended to read as follows:

A pharmacy benefit manager shall, with respect to contracts between a pharmacy benefit manager and a pharmacy or, alternatively, a pharmacy benefit manager and a pharmacy's contracting agent, such as a pharmacy services administrative organization, include a reasonable process to appeal, investigate and resolve disputes regarding multi-source generic, brand name and biologic product drug pricing. The appeals process shall include the following provisions:

§ 4. This act shall take effect immediately.

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the public health law, in relation to payments by phar- macy benefit managers to in-network pharmacies

Summary of specific provisions

Section one amends subdivision 1 of section 280-a of the public health law is amended by adding paragraphs (j) and (k).

Section 2 amends subdivision 3 of section 280-a of the public health law to add a paragraph (b)

Read the full memo (688 words)

Section 3 amends amends the opening paragraph of subdivision 4 of section 280-a of the public health law

Section 4 contains the effective date of the bill.

Justification

The Patient Access to Pharmacy Act (PAPTA) is intended to address the growing loss of community retail pharmacies throughout New York State. As has been published in many national news media outlets, large pharma- cy chains such as CVS and Walgreens have been closing brick and mortar retail community pharmacies as have independent pharmacies due to the continued declining pharmacy reimbursement rates. This decline is due to the constant battle of controlling prescription medications and is a behind the scenes battle between those who manage the prescription drug benefit plans (aka PBMs) and the pharmaceutical manufacturers (aka PHAR- MA. It is not well known that behind the screen billions of dollars are negotiated regarding prescription drug rebates which inure to the bene- fit of the PBM or PHARMA. Meanwhile PBMs continue to press down on community pharmacies by implementing pricing schemes that are below the actual cost to the pharmacy based off an antiquated pricing methodology. Community pharmacies and the patients they serve are stuck in the middle of the clash between these major giants in the health care industry.

PAPTA implements for commercial prescription plans what the New York State Medicaid Fee for Service (FFS) plan implemented across its fee for service plan in 2023, which is a new benchmark cost plan called NADAC (National Average Drug Acquisition Cost). NADAC is a monthly survey of retail pharmacies to determine actual acquisition cost and is the most transparent calculation for both brand and generic medications and is lower in price than the current benchmarks being utilized. NADAC is paired with the Medicaid FFS dispensing fee to put forth a transparent and straightforward reimbursement strategy for pharmacies in a simpli- fied format yet does not disrupt the rebate negotiations between the PBM and PHARMA. This strategy of transparency is meaningful for health plans as well since there is a better view of pharmacy level costs. As the federal government and state government look to move toward a reference pricing methodology in the future this will create security for communi- ty pharmacies. This legislation would keep community pharmacies open and address the concern about reference pricing or federal negotiated discount pricing leading to a new reimbursement directive that targets a price for medications that cannot be acquired from the smallest to larg- est of pharmacies. Currently, there is the potential for lack of access to medications for patients due to inability to acquire the medications by the pharmacies.

PAPTA is not a new idea. States such as West Virginia, Kentucky, Oregon and Arkansas have adopted this model in the last year to ensure that patients have access to pharmacies in their states. Here in New York local nonprofit health plans such as CDPHP and national plans such as United Health have introduced this concept in part or whole into their networks to help minimize pharmacy conflicts over MAC pricing and many other complaints and to maintain a stable reimbursement rate that all pharmacies are subjected too. This too will eliminate the substantiated claims that PBM owned pharmacies pay their own pharmacies a better rate than competitors and puts all community pharmacies on even footing and help restore consumer choice of pharmacy.

PAPTA also clarifies that this is not applicable to prescription drug plans established under Medicare Part D and also self-funded health plans or Employee Retirement Income Security (ERISA) plans which has been a concern from various stakeholders.

Prior legislative history

New Bill

Fiscal implications

None to the state

Effective date

This act shall take effect immediately.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.